Molecular Partners
Daniel Steiner is SVP Research of Molecular Partners. In his previous role with Molecular Partners, Daniel built the department responsible for DARPin® generation for all research pipeline projects, specifically establishing the DARPin® platform for systemic PK-extension. While earning his Ph.D. at the University of Zurich under Dr. Andreas Plückthun, Daniel established a novel in vitro selection system enabling the efficient selection of DARPin® molecules on complex antigens. In addition to his doctorate studies at University of Zurich, Daniel performed his undergraduate studies at the ETH Zürich and at the Imperial College London.
This person is not in any offices
Molecular Partners
3 followers
About Molecular Partners AG Molecular Partners AG is a clinical-stage biotech company that is developing a new class of therapies known as DARPin® therapeutics.